Phase II Study of Vinorelbine plus Estramustine in Metastatic Hormone-Refractory Prostate Cancer

Abstracts/Posters/Presentations:

• Sweeney C, Monaco F, Hanna M, Wasielewski M, Picus J, Ansari A, Dugan W, Einhorn LH. Phase II Study of Weekly Vinorelbine and Estramustine for Hormone Refractory Prostate Cancer (HRPC): a Hoosier Oncology Group and Walther Cancer Institute trial GU98-1 Accepted to the ASCO annual meeting May 20-23, 2000, New Orleans, LA

Manuscripts/Articles:

• Sweeney CJ, Monaco F, Jung SH, Wasielewski MJ, Picus J, Ansari RH, Dugan WM, Einhorn LH. A Phase II Hoosier Oncology Group Study of Vinorelbine and Estramustine Phosphate in Hormone Refractory Prostate Cancer: GU98-1. Annals of Oncology 13: 435-440, 2002. See abstract.